197 results on '"McKoy J"'
Search Results
2. LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy
3. Elevated incidence of fractures in women with invasive breast cancer
4. Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route
5. Reflections on the use of electronic health record data for clinical research
6. Reporting of Serious Adverse Events During Cancer Clinical Trials to the Institutional Review Board: An Evaluation by the REsearch on ADverse DRug Events ANd REports (RADAR) Project
7. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project
8. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy
9. Progestogens for Preterm Birth Prevention: A Systematic Review and Meta-Analysis
10. 796. Improving Clostridioides difficile Infection Treatment and Outcomes Using a Web-based Tool to Support a Care Coordination Intervention
11. Sporulation of fungi in submerged culture
12. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia
13. Impaired mitochondrial function protects against free radical-mediated cell death
14. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology
15. DNA Damage-Inducible and RAD52-Independent Repair of DNA Double-Strand Breaks in Saccharomyces cerevisiae
16. Bleomycin affects cell wall anchorage of mannoproteins in Saccharomyces cerevisiae
17. Elevated incidence of fractures in women with invasive breast cancer
18. Treatment of overactive bladder in women
19. Advancing pharmacovigilance through academic–legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis—a research on adverse drug events and reports (RADAR) report
20. Fungal cell wall septation and cytokinesis are inhibited by bleomycins
21. Elevated incidence of fractures in women with invasive breast cancer.
22. PMD73 Comparisons of Anaphylactoid Reactions Associated With Different Gadolinium Products and Iodinated Contast Media Using the FDA's Adverse Event Reporting System
23. Evidence to Inform Decisions About Maternal-Fetal Surgery Technical Brief
24. Multicenter analysis of more than 300 very elderly non-Hodgkin lymphoma (NHL) patients (pts): Impact of comorbidities and functional status on outcome.
25. Reporting of cancer clinical trial adverse drug events: A RADAR report.
26. Bisphosphonates and acute kidney injury in cancer patients: A RADAR report.
27. Herbal supplements: Boon or bane for older cancer patients?
28. PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGS
29. Hip fractures as a complication of cancer care in perimenopausal women with breast cancer.
30. Gardasil: A false sense of immunity?
31. Patient (PT) understanding of venous thromboembolism (VTE) risks associated with lenalidomide (Len) and thalidomide (Thal), previous clots, and current prophylaxis.
32. Quality not quantity: Key success factors from the first decade of safety reports from the Research on Adverse Drug Events and Reports project (RADAR)
33. Cost-effectiveness of a health care provider-directed intervention to promote colorectal cancer screening
34. Interpreting out-of-pocket expenditures for cancer patients: The importance of considering baseline household income information
35. Defining the role of patient navigators for men with an abnormal prostate cancer screening test result in an urban setting
36. Erythropoiesis-stimulating agents for cancer patients: Increasingly restrictive guidelines and policies in the United States and Europe
37. Systematic review of toxicities of lineage-specific hematopoietic growth factors toxicities: Implications for biosimilar erythropoietins, thromopoietic receptor agonists, and continuous erythropoietin receptor agonists
38. Lesions and preferential initial localization of [S-methyl-3H]bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes
39. Erythropoiesis stimulating agents (ESAs): An overview of safety-related findings from the Research on Adverse Drug Events and Reports (RADAR) project
40. The role of health literacy in patient navigation intensity prior to and post-prostate cancer diagnosis
41. The importance of timely and appropriately-sized pharmacovigilance studies in the detection of safety signals: Lessons learned from the erythropoiesis stimulating agents (ESAs) controversy
42. Tumor progression and mortality associated with administration of erythropoiesis stimulating agents (ESAs) to cancer patients: Is toxicity due to ESAs or elevated hemoglobin (Hgb) levels
43. RADAR assessment of quality of reporting of serious adverse drug reactions (sADRs) to an Institutional Review Board (IRB) for 14 clinical trials with imatinib mesylate
44. (335) The effects of neuroticism, pain catastrophizing, and disparity in emotional support on depression, pain intensity, and adjustment: A structural equations approach
45. (329) Preference of social support types and differential effects of pain controllability, perceived social support, and disparity in social support on depression and adjustment
46. Bisphosphonate use and osteonecrosis of the jaw: Pharmacovigilance and reporting of this serious adverse event from the Research on Adverse Drug Events and Reports (RADAR) project
47. Paucity of economic analyses of phase III clinical trials conducted by the cooperative oncology groups: A review of the evidence
48. Recombinant erythropoietin (Epo)/darbepoetin (Darb) associated venous thromboembolism (VTE) in the oncology setting: Findings from the Research on Adverse Drug Events And Reports (RADAR) project
49. Do post-approval phase III trials for accelerated approved cancer drugs violate equipoise?
50. Report card for accelerated FDA approval oncology drugs (1995- 2003): Is it time for a make-up test?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.